Squamous cell carcinoma cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Squamous Cell Carcinoma: An Overview
Introduction to Squamous Cell Carcinoma
Squamous cell carcinoma (SCC) is a type of cancer that arises from squamous cells, which are flat cells found in the skin and the lining of various organs. SCC can occur in different parts of the body, including the skin, head and neck, lungs, and ovaries. This article provides an overview of the epidemiology, risk factors, diagnosis, and treatment options for SCC, with a focus on cutaneous squamous cell carcinoma (cSCC) and head and neck squamous cell carcinoma (HNSCC).
Epidemiology and Risk Factors
Head and Neck Squamous Cell Carcinoma (HNSCC)
HNSCC arises from multiple anatomical subsites in the head and neck region, including the oral cavity, oropharynx, hypopharynx, and larynx. Major risk factors for HNSCC include tobacco use, alcohol dependence, and infection with oncogenic viruses such as human papillomavirus (HPV). The incidence of HPV-associated oropharyngeal cancer is increasing in developed countries and may surpass that of cervical cancer by 2020.
Cutaneous Squamous Cell Carcinoma (cSCC)
cSCC is one of the most common non-melanoma skin cancers, representing 20% to 50% of skin cancers. Risk factors for cSCC include advanced age, cumulative sun exposure, fair skin, prolonged immunosuppression, and previous skin cancer diagnoses. cSCC can arise de novo or from precursor lesions such as actinic keratosis.
Diagnosis and Staging
Diagnostic Techniques
For cSCC, diagnostic techniques such as dermoscopy and reflectance confocal microscopy have enhanced diagnostic accuracy. Proper identification of aggressive cSCCs is crucial for guiding additional work-up and management.
Staging Systems
The American Joint Committee on Cancer (AJCC) has revised the staging guidelines for cSCC to reflect recent evidence concerning high-risk clinicopathologic features. These staging systems help stratify patients into high- and low-risk groups, which is essential for determining the appropriate treatment approach .
Treatment Options
Head and Neck Squamous Cell Carcinoma (HNSCC)
Treatment for early-stage HNSCC typically involves a single modality, either surgery or radiotherapy. For locally advanced HNSCC, a multimodal approach is used, which may include surgery followed by adjuvant radiation or chemoradiation. For recurrent or metastatic disease, chemotherapy with or without a biological agent is indicated.
Cutaneous Squamous Cell Carcinoma (cSCC)
Surgical excision is the first-line treatment for invasive cSCC. Radiotherapy may be considered for patients who are not candidates for surgery. Recent advances in the understanding of cSCC pathogenesis have led to the development of new systemic therapies, including immunotherapy with immune checkpoint inhibitors like Cemiplimab and epidermal growth factor receptor inhibitors for metastatic and locally advanced cSCC .
Molecular and Genetic Insights
Recent large-scale genomic, genetic, and epigenetic studies have identified common determinants in SCCs from various body sites, suggesting a unified perspective of the disease. For instance, squamous-cell carcinomas of the lung (SQCLCs) have shown unique molecular characteristics such as SOX2 amplification, NFE2L2 and KEAP1 mutations, and PI3K pathway changes, which have led to the development of targeted therapeutic agents.
Conclusion
Squamous cell carcinoma is a heterogeneous group of cancers with varying epidemiology, risk factors, and treatment options depending on the site of origin. Advances in diagnostic techniques, staging systems, and molecular insights have significantly improved the management of SCC. Continued research and clinical trials are essential for further improving outcomes for patients with this disease.
Sources and full results
Most relevant research papers on this topic